Table 3. Changes in sales volumes of antimicrobial classes prioritized according to their medical importance for humans (WHO CIA list).
| Year | volume of IAs [t] | change [%] | volume of HIAs [t] | change [%] | volume of CIAs [t] | change [%] |
|---|---|---|---|---|---|---|
| 2011 | 23.500 | 830.674 | 851.485 | |||
| 2012 | 27.861 | 18.56 | 823.886 | -0.82 | 767.292 | -9.89 |
| 2013 | 28.668 | 2.90 | 703.794 | -14.58 | 719.157 | -6.27 |
| 2014 | 26.875 | -6.26 | 545.143 | -22.54 | 666.322 | -7.35 |
| 2015 | 20.130 | -25.09 | 349.329 | -35.92 | 435.822 | -34.59 |
| 2016 | 20.826 | 3.46 | 316.029 | -9.53 | 405.403 | -6.98 |
| 2017 | 27.831 | 33.62 | 305.607 | -3.30 | 399.670 | -1.41 |
| 2018 | 20.277 | -27.14 | 298.860 | -2.21 | 403.293 | 0.91 |
| total | -3.223 | -13.71 | -531.814 | -64.02 | -448.192 | -52.64 |
Volumes represent the quantities of active ingredient sold in the respective antimicrobial category in tons [t] within the given year. Changes expressed in percent relate to the sales volumes of the previous year.